Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback